NCT05641077

Brief Summary

The proposed VIDEO randomized trial will help inform clinical practice regarding the utility and perceived value of videoconferencing for postoperative care of urogynecologic patients by comparing patient satisfaction with virtual video visits and traditional in-office visits after pelvic organ prolapse and/or anti-incontinence surgery. Patient satisfaction will be measured by the Patient Satisfaction Questionnaire-18 at the 6-week postoperative visit. The investigators hypothesize that patient satisfaction with the virtual postoperative visit will be non-inferior to an in-office visit. The study will secondarily investigate other important components of healthcare quality, including safety and clinical outcomes, by comparing postoperative healthcare resource utilization and adverse events within 12 weeks after urogynecologic surgery. Healthcare resource utilization as measured by patient-initiated phone calls, unscheduled in-person/virtual office visits, emergency room or urgent care visits, and inpatient readmissions within 6 weeks following surgery and within 12 weeks following surgery. The study also aims to evaluate patient and provider preferences/attitudes toward in-office versus virtual-video postoperative visits.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 29, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 7, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

January 20, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2024

Completed
8 months until next milestone

Results Posted

Study results publicly available

September 26, 2024

Completed
Last Updated

September 26, 2024

Status Verified

June 1, 2024

Enrollment Period

1 year

First QC Date

November 29, 2022

Results QC Date

June 12, 2024

Last Update Submit

June 12, 2024

Conditions

Keywords

UrogynecologyVirtual visitTelehealthUrogynecologic surgeryHealthcare resource utilizationPatient satisfactionPostoperative

Outcome Measures

Primary Outcomes (1)

  • Patient Satisfaction

    Patient satisfaction will be measured by the Patient Satisfaction Questionnaire-18 (PSQ-18) at the 6-week postoperative visit. The PSQ-18 is a validated 18-item questionnaire. Responses to each question are scored on a five-point Likert scale, ranging from 1 (strongly disagree) to 5 (strongly agree). The total score for the questionnaire ranges from 18 (dissatisfaction with medical care) to 90 (highest satisfaction with medical care).

    6 weeks

Study Arms (2)

Virtual Visit

EXPERIMENTAL

Patients randomized to the experimental arm will be scheduled for and follow up with the surgeon or an advanced practice provider via a virtual visit using videoconference technology at 6 weeks after the anticipated date of surgery. If the surgery were to be rescheduled to a future date, the postoperative visit will be moved accordingly to ensure follow-up occurs at the 6-week postoperative period.

Other: Virtual Visit

Office Visit

ACTIVE COMPARATOR

Patients randomized to the active comparator arm will be scheduled for and follow up with the surgeon or an advanced practice provider via an in-office visit at 6 weeks after the planned date of surgery. If the surgery were to be rescheduled to a future date, the postoperative visit will be moved accordingly to ensure follow-up occurs at the 6-week postoperative period.

Other: Office Visit

Interventions

Patients randomized to this arm will be scheduled for and follow up with the surgeon or an advanced practice provider via a virtual visit using videoconference technology at 6 weeks after the anticipated date of surgery. If the surgery were to be rescheduled to a future date, the postoperative visit will be moved accordingly to ensure follow-up occurs at the 6-week postoperative period.

Virtual Visit

Patients randomized to this arm will be scheduled for and follow up with the surgeon or an advanced practice provider via an in-office visit at 6 weeks after the planned date of surgery. If the surgery were to be rescheduled to a future date, the postoperative visit will be moved accordingly to ensure follow-up occurs at the 6-week postoperative period.

Office Visit

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsUrogynecological post-operative study
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age greater than 18 years old
  • Has technological capability to participate in videoconferencing (high-speed internet access with desktop computer or mobile device)
  • Has decision-making capacity and able to provide informed consent for research participation
  • Able to speak and read English

You may not qualify if:

  • Patient requested to physically come in the office or have a virtual visit for her postoperative visit
  • Planned concomitant surgery with another surgical team
  • Office follow-up is deemed medically necessary by provider/surgeon

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cleveland Clinic

Cleveland, Ohio, 44195, United States

Location

Related Publications (1)

  • Lua-Mailland LL, Nowacki AS, Paraiso MFR, Park AJ, Wallace SL, Ferrando CA. Virtual Compared With In-Office Postoperative Visits After Urogynecologic Surgery: A Randomized Controlled Trial. Obstet Gynecol. 2024 Oct 1;144(4):562-572. doi: 10.1097/AOG.0000000000005694. Epub 2024 Aug 8.

MeSH Terms

Conditions

Patient Satisfaction

Interventions

Office Visits

Condition Hierarchy (Ancestors)

Treatment Adherence and ComplianceHealth BehaviorBehavior

Intervention Hierarchy (Ancestors)

Professional PracticeOrganization and AdministrationHealth Services Administration

Results Point of Contact

Title
Lannah Lua-Mailland
Organization
Cleveland Clinic

Study Officials

  • Cecile A Ferrando, M.D., M.P.H.

    The Cleveland Clinic

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 29, 2022

First Posted

December 7, 2022

Study Start

January 20, 2023

Primary Completion

January 31, 2024

Study Completion

January 31, 2024

Last Updated

September 26, 2024

Results First Posted

September 26, 2024

Record last verified: 2024-06

Locations